Femring Reviews: What Women Report, What the Label Shows and Real-World Tips

By The HRT Index Editorial Team · Editorial research — not medically reviewed · Last verified October 2026

Femring reviews are mostly positive. On October 31, 2026, Drugs.com showed 8.7 out of 10 from 37 reviews, and 22 of 29 WebMD reviewers who named Femring gave it 4 or 5 stars. Women praise hot flash relief and more comfortable sex. The top complaints are cost, the ring wearing off before 90 days, infections and slipping out.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

What we actually verified · Last verified October 2026

• What we read: all 37 Femring reviews on Drugs.com, one by one; all 557 reviews on WebMD's shared vaginal estradiol review page, which pools Femring with Estring, creams and tablets, searched one by one for every review that names Femring (we found 29); the current Femring prescribing information, patient information and instructions for use on DailyMed, including its clinical trial, side effect and blood level data; the current Estring label for comparison; The Menopause Society's 2022 hormone therapy position statement; MedlinePlus patient information on vaginal estrogen; the FDA's November 2025 request to change menopause hormone therapy labels, its February 2026 approval announcement and its list of updated labels; and Millicent Pharma's product page. Every source is listed at the bottom with the date we read it.
• What we did not do: we did not use Femring ourselves, contact reviewers, examine anyone or speak with a clinician for this page. We didn't write or edit any review, and we don't publish star ratings of our own. This is editorial research, not medical review, and not advice for your situation.
• Commercial interest: The HRT Index may earn a commission from some providers featured through The HRT Index's Find My HRT Path tool. No drug maker or provider paid for this page or reviewed it, and we don't earn anything from Femring sales. See our affiliate disclosure.
• Verification Standard: we judge online menopause care on five pillars, in this order: clinical legitimacy, care quality, medication fit, price transparency and access. Our methodology explains how.

Jump to: Scorecard · What it is · What reviews say · Wearing off early · Does it work? · Side effects · Comfort and falling out · Bleeding and progesterone · Boxed warning and FDA changes · Who shouldn't use it · Cost and coverage · Femring vs other options · Who tends to do well · Questions to ask · Online care · FAQ · Sources

Femring reviews at a glance: the scorecard

Here's the short version, built from the review data we read on October 31, 2026 and from the FDA label. We don't give Femring a score of our own. Reviews are personal, unverified reports, so we treat them as a guide to what to ask about, not proof of what will happen to you.

What Femring is, in plain terms

Femring is a soft, flexible silicone ring that you put in your vagina and leave there for 3 months. Its core holds estradiol acetate, which your body turns into estradiol, the main estrogen your ovaries make before menopause. It's made by Millicent Pharma.

According to the FDA label, Femring is approved for two uses:

• Moderate to severe hot flashes and night sweats (the label calls them vasomotor symptoms) due to menopause
• Moderate to severe vulvar and vaginal atrophy due to menopause, meaning dryness, irritation and pain with sex. The patient information says that if you only need treatment for changes in and around your vagina, you should talk with your clinician about whether a topical vaginal product would be better for you.

A few facts from the label shape almost every review:

• It's systemic estrogen. This is the single most important thing to understand. Even though it sits in your vagina, Femring is designed to raise estrogen levels through your whole body. The label says that although Femring is used only in the vagina, "the risks associated with oral estrogens should be taken into account."
• There are two strengths. One ring releases the equivalent of 0.05 mg of estradiol a day, and the other releases 0.10 mg a day, both for 3 months. The label says to start with 0.05 mg a day and adjust based on how you respond.
• One ring lasts 90 days. You take it out after 90 days and, if you and your clinician decide to continue, put in a new one.
• You can usually insert it yourself. You press the sides together, often into a figure-eight shape, and push it up toward your lower back. The label says its exact position doesn't matter for it to work.
• It skips the liver's first pass. Estrogen absorbed through the vaginal wall reaches your bloodstream without passing through the liver first, the way a pill does. The label notes that blood estradiol levels on Femring were slightly higher than estrone levels, consistent with that.

Femring is not Estring

This matters because several reviewers mixed them up. One wrote that Estring is "the same thing, different brand." It isn't.

So Femring's 0.05 mg strength releases more than 6 times as much estradiol each day as Estring, and the 0.10 mg strength more than 13 times as much. The Menopause Society's 2022 position statement puts it simply: one ring delivers low-dose estradiol to the vagina, "but another is aimed at providing systemic levels of estradiol." Our Femring vs Estring comparison goes through the differences in detail.

What Femring reviews say: patterns from 65 real reviews

Femring has been sold for many years, but the number of public reviews is still modest, and many are old. That's worth knowing before you give any average too much weight.

• Drugs.com had 37 Femring reviews when we checked on October 31, 2026, with an average rating of 8.7 out of 10. It reported that 84% of reviewers had a positive experience and 8% a negative one. Of the 37, 32 were for menopause symptoms, 3 for vaginal atrophy and 1 for urinary symptoms (atrophic urethritis). The newest was from January 2023.
• WebMD doesn't have a Femring-only page. Femring reviews sit on a page titled "Estradiol vaginal (Estrace, Estring, Vagifem)," which showed an overall rating of 3.5 out of 5 from 557 reviews. That number mostly reflects other products, so it isn't a Femring rating. We read every review on that page and found 29 that name Femring.

Here's what the 29 WebMD Femring reviews showed:

• 22 rated it 4 or 5 out of 5. 5 rated it below 3, and one of those was a question from a new user rather than a review.
• They span January 2008 to January 2026. Most are more than ten years old, and only five were posted after 2014.
• 13 reviewers said they were 55 to 64 years old, 6 were 45 to 54, 5 were 35 to 44, and 4 were 65 to 74. One didn't give an age group.

One review appears word for word on both sites, so we counted it as one experience. In all, that's 65 different reviews across the two sites.

A small, self-selected group can still be useful. People with strong experiences, good or bad, are the ones who post. Reviewers don't have to prove what they used, and old reviews may describe a different price or insurance picture from today's. Treat these as examples of what can happen, not as odds.

The right online menopause care isn't the same for every woman — it depends on your symptoms, what you've already tried, your age, your state and your health history. Some situations belong with an in-person clinician first. Use The HRT Index's Find My HRT Path tool to explore a featured care option for your situation — and to flag when online care isn't the right starting point — before your first consult.

Find My HRT Path is free, takes about 60 seconds and doesn't ask for your email. It asks about your symptoms, what you've already tried, your age, your state and your health history. It isn't an eligibility test or a diagnosis, and it can't tell you whether Femring is right for you.

What reviewers liked

• Hot flashes and night sweats went away. "No more hot flashes, no night sweats, no moodiness," wrote a Drugs.com reviewer using the 0.05 mg ring after a hysterectomy. A 42-year-old WebMD reviewer said she could see a difference within days, and "by 10 days they were completely gone." Another, who started after having her uterus and ovaries removed, said her hot flashes disappeared "within days."
• Sex became comfortable again. This was one of the most common themes. A 74-year-old Drugs.com reviewer said she'd used it for 9 years "with wonderful results" and could have "a regular and full sex life" again. Another said it "remedied vaginal dryness and renewed my sex life." A woman with severe atrophy said her gynecologist later reported her tissue "looked healthy."
• Mood and steadiness. Several reviewers described less moodiness, irritability or brain fog. "Femring 0.1 is the only thing that has really worked for all my symptoms, especially moodiness, depression," wrote one.
• Not having to think about it. "1 every 3 months is great. I forget I have it," wrote one early reviewer. Several women who had trouble with patches, because they burned their skin, didn't stay on or triggered an adhesive allergy, said the ring solved that.
• Comfort, for most. At least five Drugs.com reviewers said they couldn't feel it once it was in. "Once I put it in, I never feel it," wrote a woman who had used it for many years after a hysterectomy.
• Urinary symptoms. One reviewer said it "completely took care of my urinary burning and frequency."

What reviewers didn't like

• Cost. By far the most common complaint. On Drugs.com, 20 of 37 reviewers described the price or insurance as a downside, and at least 5 said they stopped or switched products because of cost or lost coverage. On WebMD, 7 of the 29 complained about price. "The only bad thing is the cost," wrote one long-term user.
• It wore off before 90 days. Nine reviewers said so. We cover this in detail below.
• Infections. Reviewers described repeated yeast infections, a bacterial infection, and one case of abdominal pain, fever and chills that eased after the ring came out. One woman said her clinician found the ring had caused "erosion" of her vaginal wall.
• Slipping out or breaking. Four reviewers said the ring came out or nearly came out, during a bowel movement, with IBS symptoms or during sex. One of them said her rings also broke, and she switched to a cream.
• Breast and nipple pain. A WebMD reviewer removed it after 11 days because of very painful nipples and said she gained 4 pounds of water weight. A Drugs.com reviewer said breast tenderness was her only side effect.
• Bleeding. One reviewer started bleeding and cramping in her first month, and her gynecologist wanted to do an endometrial biopsy. Another had a heavy period-like bleed after a year and had an ultrasound.
• Mood and skin. One reviewer said she felt like she was "having PMS all day, every day." Others described a rash on the neck, acne on the chin, nervousness or hair loss.
• Fit. One reviewer found it "quite hard, large, and terribly uncomfortable." Another said it "felt too big and pressed on my bladder."

Who wrote these reviews

A striking number of reviewers had had a hysterectomy, their ovaries removed, or both: 7 on Drugs.com and 8 on WebMD. Several went into surgical menopause in their 20s or 30s. That fits with Femring being a systemic estrogen. Women without a uterus usually don't need a progestogen, so estrogen alone can be simpler for them. It also means some of these experiences may not match yours if you still have a uterus. Our HRT after hysterectomy and surgical menopause guides cover that situation.

Three things in the reviews that aren't accurate

Reviews are honest experiences, but a few contain claims that don't match the label:

• "Estring is the same thing, different brand." No. Estring is a low-dose local ring for vaginal symptoms, and Femring is a systemic ring that also treats hot flashes. See the table above.
• "Estradiol acetate... has to pass through the liver." The label says estrogen from Femring avoids the liver's first pass. Another reviewer pointed this out in reply.
• "Prescribed 0.5 mg." Two reviewers wrote this. Femring comes in 0.05 mg and 0.10 mg a day. There is no 0.5 mg ring, so these were most likely typos for 0.05 mg.

One reviewer also said she used Femring because she had a liver disorder. The Femring label lists known liver impairment or disease as a reason not to use it. We can't know her full history, but if you have liver disease, this is something to raise with your clinician rather than take from a review.

Does Femring wear off before 90 days? What reviewers say

The most specific complaint in Femring reviews isn't a side effect. It's the feeling that the ring stops working before its 90 days are up. Nine reviewers described it, and they were remarkably consistent.

• "It definitely doesn't last for 90 days," wrote a woman on the 0.10 mg ring, who said it had lasted "8 or 9 weeks at most" and once only 6 weeks.
• A woman who had her ovaries removed at 35 said her symptoms came back around day 60 with her first ring and around day 35 with her second.
• Two women in their 70s said they change it at 75 days, and both said they notice no drop-off that way. One of them wrote that it "doesn't last the full 90 days as advertised."
• One WebMD reviewer said her gynecologist told her she writes prescriptions to change the ring every 2 months "for almost all her patients."
• Others said symptoms returned at 7 to 8 weeks or after about 60 days, and one said her husband "can tell when the 3mon are almost up."

What the label says

The label says each ring releases its dose "for 3 months" and that "after 90 days, Femring may no longer release enough medicine to control your menopausal symptoms." It doesn't describe the effect fading earlier than that.

The label's blood level data adds something useful. Estradiol peaks within about an hour of putting in a new ring, then falls over the first 24 to 48 hours before settling at a fairly steady level for the rest of the 3 months. The label also notes that, in lab studies, this first burst is higher as rings age in storage. That may help explain why several reviewers described a "surge" of estrogen, or feeling "edgy" or "giddy," in the first few days. One WebMD reviewer said the first few days brought more hot flashes before things settled.

What this means for you

We can't tell from reviews why some women feel the ring fading early. It could be dose, how their body handles estrogen, or other things going on. The point is to tell your clinician if your symptoms reliably come back before day 90, rather than changing the schedule on your own. Insurance may also limit how often you can fill it, as several reviewers found. Ask your clinician whether a different dose, timing or form of estrogen might suit you better. Our guides to signs your HRT dose is too low and the HRT equivalent dose chart can help you prepare.

Does Femring work? What the trial found

With reviews this old and this few, the clinical trial in the label is the steadier guide.

Hot flashes

In a 13-week trial, 333 postmenopausal women aged 29 to 85 who had at least 7 moderate to severe hot flashes a day (or 56 a week) were randomly assigned to a placebo ring, the 0.05 mg Femring or the 0.10 mg Femring. Here's what happened to moderate to severe hot flashes:

Both doses were significantly better than placebo at weeks 4 and 12, for both how often hot flashes happened and how severe they were. In everyday terms, women on the 0.05 mg ring went from about 10 to 11 hot flashes a day to about 2 a day by week 12. On the 0.10 mg ring, it was about 1 a day. Women on the placebo ring improved too, to about 6 a day, which is common in hot flash studies and one reason single reviews can mislead.

Vaginal symptoms

In the same trial, the share of mature surface cells in the vaginal lining rose by an average of 16.0% on the 0.05 mg ring and 18.9% on the 0.10 mg ring by week 13, compared with 1.11% on placebo. Vaginal pH, which tends to rise after menopause, fell more on both Femring doses than on placebo. Those are signs that estrogen is reaching the tissue, and they match reviewers who said sex became comfortable again.

How fast does it work?

In the trial, hot flashes were already much lower by week 4, the first point reported. Several reviewers described relief within days, and one said it took about three weeks for her depression to go away. Our guide to how long HRT takes to start working explains why timing varies.

What The Menopause Society says

The Menopause Society's 2022 position statement says hormone therapy "remains the most effective treatment" for hot flashes and the genitourinary syndrome of menopause. For women younger than 60 or within 10 years of menopause who have no contraindications, it says the benefit-risk ratio is favorable for bothersome hot flashes and preventing bone loss. It lists vaginal rings among the ways systemic estrogen can be given. For vaginal symptoms alone, it says the preference is low-dose vaginal therapy. See our guide to vaginal estrogen vs systemic estrogen.

Femring side effects: what the trial and reviewers report

In the 13-week trial, these side effects were reported by at least 2% of women on Femring:

The label says the most common side effects, in more than 5% of users, are vaginal bleeding and breast tenderness. Bleeding, yeast infections and breast tenderness were all more common on the higher dose, which lines up with reviewers' reports.

The patient information lists these as less serious but common side effects: headache, breast tenderness or pain, irregular vaginal bleeding or spotting, stomach cramps and bloating, nausea and vomiting, hair loss, fluid retention, vaginal yeast infection, and burning, irritation or itching from inserting the ring.

Problems specific to vaginal rings

The label lists rare but serious problems that have been reported with vaginal rings:

• Toxic shock syndrome (TSS). A few cases have been reported. The patient information says to remove the ring and call your clinician right away if you have fever, nausea or vomiting, diarrhea, muscle pain, dizziness, feeling faint, or a sunburn-like rash on your face or body.
• The ring sticking to the vaginal or bladder wall. This can make removal difficult and may need surgery. Vaginal erosion and ulceration have been reported with other estradiol vaginal rings. Contact your clinician if you have trouble removing it.
• Bowel obstruction. A few cases have been reported in women using vaginal rings.
• Accidental placement in the bladder. A few cases have been reported, and the label says persistent unexplained urinary symptoms should be carefully evaluated.

The label's list of reports since approval also includes rash, hair growth, weight increase or decrease, fluid retention, mood changes, nervousness, irritability, nipple pain and changes in sex drive. The label notes that because these reports are voluntary, it isn't always possible to tell how often they happen or whether the ring caused them.

When to get help

The patient information says to call your healthcare provider right away if you notice:

• new breast lumps
• unusual vaginal bleeding
• changes in vision or speech
• sudden new severe headaches
• severe pains in your chest or legs, with or without shortness of breath, weakness and fatigue

In an emergency, call 911. For more, see our HRT side effects guide, signs your HRT dose may be too high and vaginal estrogen side effects.

Comfort, sex and when Femring falls out

Most reviewers said they couldn't feel Femring once it was in, but a minority found it uncomfortable, and a few had it slip out. The label explains the common causes.

If it feels uncomfortable

The instructions say that if the ring feels uncomfortable, you may not have pushed it in far enough, and to use your finger to push it as far up as you can. One reviewer who loved it said it "can be difficult to insert at first, but no different than a diaphragm." Another wasn't able to insert or remove it herself and had her OB/GYN change it every 3 months, which is an option to ask about. Our step-by-step guide on how to use an estrogen vaginal ring covers insertion, removal and troubleshooting.

If it falls out

The label says Femring can come out if:

• it isn't put in far enough
• you push hard during a bowel movement
• your vaginal muscles are weak

If it comes out before 90 days, the instructions say to clean it with warm water and put it back in. If it comes out often, tell your clinician, because Femring may not be right for you. If you lose it, the label says a new ring should be put in for 90 days. Reviewers' experiences fit this list. One with IBS said it fell out (and broke) three times, one learned to check before flushing after it nearly slipped out while she was constipated, and one said it came out twice during sex. If your cervix, bladder or rectum has dropped into the vagina (prolapse), the patient information says this may make the ring harder to keep in place.

Sex

The label says you can leave Femring in during sex. If it comes out, or you take it out, clean it with warm water and put it back. Several reviewers said their partners didn't notice it, and one said her partner could feel it "occasionally but never enough to bother him." One reviewer stopped after 3 weeks because it gave her an infection and, she said, disrupted her sex life. Another developed bleeding after sex and a bacterial infection, and was told the ring had caused erosion of her vaginal wall.

Infections and the ring

You can leave Femring in while using medicine for a vaginal infection, according to the label. Yeast infections were more common on Femring than on placebo in the trial. If you have unusual discharge, pain, fever or bleeding, contact your clinician rather than waiting it out, especially given the rare ring-related problems above. The label also says contact with blood may discolor the ring and that this doesn't affect how it releases medicine.

Bleeding and whether you need progesterone with Femring

Femring is estrogen only. If you still have a uterus, estrogen alone raises the risk of endometrial (uterine lining) cancer. The label says that when estrogen is prescribed for a postmenopausal woman with a uterus, a progestin "should also be considered" to reduce that risk, and the patient information says adding one is generally recommended. The Menopause Society's 2022 statement says women with a uterus using systemic estrogen "should receive adequate progestogen."

A woman without a uterus doesn't need a progestin, according to the label, though some women who had a hysterectomy and have a history of endometriosis may. Our guides to whether you need progesterone if you have a uterus and estrogen-only vs estrogen plus progesterone explain the choices. Note that this is different from low-dose vaginal estrogen like Estring. See do you need progesterone with vaginal estrogen for that question.

Two Femring reviewers described bleeding. One started bleeding and cramping within her first month, and her gynecologist recommended an endometrial biopsy. She wrote that she felt the biopsy was "a little over the top." The label disagrees with that instinct. It says abnormal bleeding in postmenopausal women needs proper testing, including endometrial sampling when indicated, to rule out cancer. If you have new, persistent or unexpected bleeding, tell your clinician. Don't assume it's a normal side effect. See bleeding after starting HRT for what's expected and what isn't.

The boxed warning, and what the FDA's 2025–2026 changes mean for Femring

The current label still has the full boxed warning

The Femring label on DailyMed (version published December 2025) carries a boxed warning for endometrial cancer, cardiovascular disorders, breast cancer and probable dementia. Those warnings come mainly from the Women's Health Initiative (WHI), a large trial of daily oral conjugated estrogens, with or without medroxyprogesterone acetate, in women aged 50 to 79. The WHI didn't study Femring. The label says that without comparable data, these risks should be assumed to be similar for other doses and forms of estrogen.

What the FDA changed

On November 10, 2025, the FDA asked makers of all menopause hormone therapy to change their labels. In the boxed warning, it asked them to remove the language about cardiovascular disease, breast cancer and probable dementia, and to drop the advice to use the lowest dose for the shortest time. It asked that the endometrial cancer warning stay in the boxed warning for systemic estrogen-alone products like Femring.

On February 12, 2026, the FDA announced it had approved the first updated labels. When we checked the FDA's list of products with updated prescribing information on October 31, 2026, Estring was on it, and Estring's DailyMed label no longer had a boxed warning. Femring was not on the list, and its DailyMed label still showed the older boxed warning.

What that means for you

The FDA has asked for these changes, but Femring's label hadn't been updated when we checked. Even after an update, the endometrial cancer warning is expected to stay for systemic estrogen-only products like Femring, and the contraindications below still apply. Our menopause hormone therapy safety update explains the changes in more detail.

The patient information also says to have a pelvic exam, breast exam and mammogram every year unless your clinician tells you otherwise, and to talk with your clinician regularly, every 3 to 6 months, about your dose and whether you still need treatment.

Who shouldn't use Femring

The label says not to use Femring if you have:

• abnormal genital bleeding that hasn't been diagnosed
• breast cancer now, suspected, or in the past
• a known or suspected estrogen-dependent cancer
• a blood clot in your legs or lungs now or in the past
• a stroke or heart attack now or in the past
• known liver impairment or disease
• a known blood clotting disorder, such as protein C, protein S or antithrombin deficiency
• a past anaphylactic reaction or angioedema with Femring
• a known or suspected pregnancy

The patient information says your clinician may need to check you more carefully if you have asthma, epilepsy, diabetes, migraine, endometriosis, lupus, angioedema, or problems with your heart, liver, thyroid or kidneys, or high calcium levels. If you're having surgery or will be on bed rest, the label says to stop estrogen 4 to 6 weeks beforehand when possible. Some medicines and supplements, including St. John's wort, can change how estrogen is broken down, so tell your clinician everything you take.

One WebMD reviewer said her doctor stopped Femring because breast cancer ran in her family, and she wanted to restart it. That's a decision to make with a clinician who knows your full history. See who shouldn't take HRT and HRT and blood clots.

Femring cost, coverage and availability

Cost was the top complaint in Femring reviews. Reviewers described everything from a modest copay to paying several hundred dollars a ring when coverage changed, and some stopped because they couldn't afford it. One spent 5 months appealing after her insurer dropped Femring from its formulary. Prices and coverage change, so we keep them on a separate page that we check and date: Femring cost without insurance.

On generics: Drugs.com listed no lower-cost generic approved for Femring when we checked on October 31, 2026. Several reviewers said they were hoping for one.

On availability: we found no sign that Femring has been discontinued. On October 31, 2026, its DailyMed listing showed no marketing end date, and Millicent Pharma's product page still listed Femring. Individual pharmacies may not keep it in stock, so it's worth calling ahead. If you're comparing ways to get a ring prescribed, see Femring online prescription and estradiol vaginal ring online.

Femring vs other estrogen options: how reviews and labels compare

Femring is one of several ways to take systemic estrogen. Here's how it compares on the things reviewers care about, based on the labels and our other review pages.

A few honest notes. Several Femring reviewers came to it after patches or other forms failed them, so the reviews are tilted toward women for whom Femring worked better than what they had tried. And the review counts for every product here are small. Neither form is better for everyone.

If your main problem is vaginal dryness or painful sex rather than hot flashes, low-dose vaginal estrogen is usually considered first. See vaginal estrogen, vaginal estrogen ring vs cream, estradiol vaginal cream reviews and Premarin vaginal cream reviews.

Who tends to do well on Femring, and who struggles

Based on the label and the patterns in reviews, here's who Femring may suit and who may want to talk through other options. This isn't a substitute for a clinician's judgment.

It may suit you if:

• you have hot flashes or night sweats and vaginal dryness, and you've talked through the benefits and risks of systemic estrogen with a clinician
• patches irritate your skin or won't stay on, or you'd rather not take a daily pill or gel
• you're comfortable inserting and removing a ring, or your clinician can do it for you
• you've had a hysterectomy, so estrogen alone may be an option

You may struggle, or need a different plan, if:

• you have a uterus and haven't talked about progestogen protection
• you only have vaginal symptoms, in which case low-dose vaginal estrogen is usually tried first
• you have significant prolapse, weak pelvic floor muscles or frequent straining with bowel movements
• you're prone to yeast infections
• cost or insurance coverage is uncertain for you
• you have any of the conditions in the contraindications list above

Questions to ask your clinician about Femring

• Do I need systemic estrogen, or would a low-dose vaginal product be enough?
• Should I start on 0.05 mg or 0.10 mg, and how will we decide whether to change?
• Do I need a progestogen, and which one?
• What should I do if my symptoms come back before day 90?
• Can you insert or remove the ring for me if I have trouble?
• Which signs of infection or bleeding need a call?
• Is Femring covered by my plan, or would another estrogen be more affordable?
• How do the FDA's 2025–2026 label changes apply to me?

Write your answers down. The patient information suggests reviewing your dose and whether you still need treatment every 3 to 6 months.

Can you get Femring through online menopause care?

Some online menopause services prescribe estrogen rings, though which products they offer varies. Our Femring online prescription guide covers what to expect. Here's how our five pillars apply:

• Clinical legitimacy: a licensed clinician should take a full history before prescribing, including any abnormal bleeding and any history of breast cancer, clots, stroke, heart disease or liver disease.
• Care quality: look for clear follow-up, a plan for side effects, early wear-off and unexpected bleeding, and a route to in-person care when you need an exam.
• Medication fit: a good service can discuss more than one estrogen option, such as a ring, patch, gel or pill, plus progestogen protection if you have a uterus and nonhormonal choices if estrogen isn't right for you.
• Price transparency: you should know what visits, refills and the medicine itself are likely to cost before you start.
• Access: you'll still need regular breast and pelvic exams and mammograms, and some problems, like bleeding, trouble removing the ring or signs of infection, need an in-person visit.

See is online HRT safe? for how to judge a service.

Frequently asked questions

Are Femring reviews mostly good or bad?

Mostly good. On October 31, 2026, Drugs.com showed an average of 8.7 out of 10 from 37 reviews, with 84% reporting a positive experience. On WebMD, 22 of the 29 reviewers who named Femring rated it 4 or 5 out of 5. Cost was the most common complaint.

Does Femring really last 90 days?

The label says to replace it after 90 days. Nine reviewers said it seemed to wear off earlier, often after 6 to 9 weeks. If your symptoms reliably return before day 90, talk with your clinician rather than changing the schedule yourself.

Is Femring the same as Estring?

No. Femring is a systemic estrogen that treats hot flashes and vaginal symptoms, releasing the equivalent of 0.05 mg or 0.10 mg of estradiol a day. Estring releases about 7.5 micrograms a day for vaginal symptoms only.

What are the most common side effects of Femring?

In the trial, vaginal bleeding and breast tenderness were the most common. Headache, vaginal yeast infections, back pain and bloating were also reported. Reviewers most often described infections, breast or nipple pain, bleeding and mood changes.

What should I do if Femring falls out?

The label says to clean it with warm water and put it back in. If it keeps coming out, tell your clinician, because Femring may not be right for you. If you lose it, a new ring should be put in for 90 days.

Do I need progesterone with Femring?

If you have a uterus, usually yes. The label says a progestin should be considered and the patient information says it's generally recommended, because estrogen alone raises the risk of endometrial cancer. If you've had a hysterectomy, you usually don't need one.

Does Femring still have a black box warning?

Yes, when we checked on October 31, 2026. The FDA asked in November 2025 for changes to menopause hormone therapy boxed warnings and approved the first updated labels in February 2026, but Femring wasn't on the FDA's updated-label list. For estrogen-only products, the endometrial cancer warning is expected to stay.

Has Femring been discontinued?

We found no sign of that. On October 31, 2026, its DailyMed listing showed no marketing end date, and Millicent Pharma's product page still listed it. Some pharmacies may need to order it in.

Can Find My HRT Path tell me if Femring is right for me?

No. Find My HRT Path asks about your symptoms, what you've tried, your age, your state and your health history, and points you to a featured care option or flags when online care isn't the right start. Only a clinician who knows your history can decide on a prescription.

The bottom line

Femring reviews are mostly positive, especially from women who struggled with patches or went into surgical menopause, and especially about hot flashes and sex. The label's trial backs that up, with large drops in hot flashes on both doses. The recurring downsides are cost, the ring seeming to fade before 90 days, infections and slipping out. Femring is systemic estrogen, not a local vaginal product like Estring, so it carries the full boxed warning and you'll need progestogen protection if you have a uterus.

If you're weighing Femring against other ways to treat hot flashes and vaginal symptoms, Find My HRT Path can help you see what fits and flag when in-person care should come first.

Related reading

• Femring vs Estring
• Femring online prescription
• Femring cost without insurance
• How to use an estrogen vaginal ring
• Estradiol vaginal ring online
• Estring online prescription
• Estradiol patch reviews
• EstroGel reviews

Sources

All sources were read on October 31, 2026.

1. Femring (estradiol acetate vaginal ring) prescribing information, patient information and instructions for use, Millicent US, Inc. DailyMed, US National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7aaa97f9-a9d1-c815-e053-2991aa0afb9e
2. Femring user reviews and ratings. Drugs.com. https://www.drugs.com/comments/estradiol/femring.html
3. Femring alternatives compared. Drugs.com. https://www.drugs.com/compare/femring
4. Estradiol vaginal (Estrace, Estring, Vagifem) user reviews. WebMD. https://reviews.webmd.com/drugs/drugreview-estradiol-vaginal-estrace-estring-vagifem
5. Estring (estradiol vaginal system) prescribing information, Pfizer. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=110b9865-5a07-4d45-b560-e89947f12600
6. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 2022;29(7):767–794. https://pubmed.ncbi.nlm.nih.gov/35797481/
7. Estrogen Vaginal. MedlinePlus Drug Information, US National Library of Medicine. https://medlineplus.gov/druginfo/meds/a606005.html
8. US Food and Drug Administration. FDA requests labeling changes related to safety information to clarify benefit/risk considerations of menopausal hormone therapy (November 10, 2025). https://www.fda.gov/drugs/drug-alerts-and-statements/fda-requests-labeling-changes-related-safety-information-clarify-benefitrisk-considerations
9. US Food and Drug Administration. FDA approves labeling changes for menopausal hormone therapy products (February 12, 2026). https://www.fda.gov/news-events/press-announcements/fda-approves-labeling-changes-menopausal-hormone-therapy-products
10. US Food and Drug Administration. Menopausal hormone therapies with updated prescribing information. https://www.fda.gov/drugs/drug-safety-and-availability/menopausal-hormone-therapies-updated-prescribing-information
11. Millicent Pharma. Our products. https://millicentpharma.com/our-products/
12. US Food and Drug Administration. MedWatch: the FDA safety information and adverse event reporting program. https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program

This page is for education only and is not medical advice. It doesn't replace an examination, diagnosis or treatment plan from a clinician who knows your health history. If you have unusual vaginal bleeding, a new breast lump, changes in vision or speech, a sudden severe headache, severe pain in your chest or legs, swelling of your face, lips or tongue, signs of toxic shock syndrome, or trouble removing your ring while using Femring, contact a clinician promptly or call 911 in an emergency. You can report side effects to the FDA through MedWatch at 1-800-FDA-1088.